|
Originally published In Press as doi:10.1074/jbc.M102350200 on April 25, 2001
J. Biol. Chem., Vol. 276, Issue 26, 23589-23598, June 29, 2001
Site-specific Charge Interactions of -Conotoxin MI with the
Nicotinic Acetylcholine Receptor*
Rao V. L.
Papineni ,
Jovanny Ulloa
Sanchez§,
Krishna
Baksi§,
Irmgard Ursula
Willcockson ¶, and
Steen E.
Pedersen
From the Department of Molecular Physiology and
Biophysics, Baylor College of Medicine, Houston, Texas 77030 and the
§ Department of Anatomy and Cell Biology, Universidad
Central del Caribe, Bayamon, Puerto Rico 00960-6032
We have tested the importance of charge
interactions for -conotoxin MI binding to the nicotinic
acetylcholine receptor (AChR). Ionic residues on -conotoxin MI were
altered by site-directed mutagenesis or by chemical modification. In
physiological buffer, removal of charges at the N terminus,
His-5, and Lys-10 had small (2-4-fold) effects on binding
affinity to the mouse muscle AChR and the Torpedo AChR. It
was also demonstrated that conotoxin had no effect on the
conformational equilibrium of either receptor, as assessed by the
effects of the noncompetitive antagonist proadifen on conotoxin binding
and, conversely, the effect of conotoxin on the affinity of
phencyclidine, proadifen, and ethidium. Conotoxin displayed higher
binding affinity in low ionic strength buffer; neutralization of Lys-10
and the N terminus by acetylation blocked this affinity shift at the
 site but not at the  site. It is concluded that Ctx
residues Lys-10 and the N terminal interact with oppositely charged
receptor residues only at the  site, and the two sites have
distinct arrangements of charged residues. Ethidium fluorescence
experiments demonstrated that conotoxin is formally competitive with a
small cholinergic ligand, tetramethylammonium. Thus, -conotoxin MI
appears to interact with the portion of the binding site responsible
for stabilizing agonist cations but does not do so with a cationic
residue and is, consequently, incapable of inducing a conformational change.
*
This work was supported in part by United States Public
Health Service Grants NS35212 (to S. E. P.) and 2G12RR3035 (to
K. B.) and Robert A. Welch Foundation Grant Q-1406 (to S. E. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by USPHS Grant T32-HL07676. Current address:
Dept. of Health Informatics, School of Allied Health Sciences,
University of Texas Health Science Center at Houston, 7000 Fannin,
Suite 600, Houston, TX 77030.
To whom correspondence should be addressed. Tel.:
713-798-3888; Fax: 713-798-3475; E-mail: pedersen@bcm.tmc.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. U. Willcockson, A. Hong, R. P. Whisenant, J. B. Edwards, H. Wang, H. K. Sarkar, and S. E. Pedersen
Orientation of d-Tubocurarine in the Muscle Nicotinic Acetylcholine Receptor-binding Site
J. Biol. Chem.,
October 25, 2002;
277(44):
42249 - 42258.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|